Your browser doesn't support javascript.
loading
Guide-free Cas9 from pathogenic Campylobacter jejuni bacteria causes severe damage to DNA.
Saha, Chinmoy; Mohanraju, Prarthana; Stubbs, Andrew; Dugar, Gaurav; Hoogstrate, Youri; Kremers, Gert-Jan; van Cappellen, Wiggert A; Horst-Kreft, Deborah; Laffeber, Charlie; Lebbink, Joyce H G; Bruens, Serena; Gaskin, Duncan; Beerens, Dior; Klunder, Maarten; Joosten, Rob; Demmers, Jeroen A A; van Gent, Dik; Mouton, Johan W; van der Spek, Peter J; van der Oost, John; van Baarlen, Peter; Louwen, Rogier.
Afiliación
  • Saha C; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Mohanraju P; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands.
  • Stubbs A; Clinical Bioinformatics, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Dugar G; Institute of Molecular Infection Biology (IMIB)/Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany.
  • Hoogstrate Y; Clinical Bioinformatics, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Kremers GJ; Optical Imaging Center, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van Cappellen WA; Optical Imaging Center, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Horst-Kreft D; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Laffeber C; Department of Molecular Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Lebbink JHG; Department of Molecular Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Bruens S; Department of Radiation Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Gaskin D; Department of Molecular Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Beerens D; Institute of Food Research, Gut Health and Food Safety Programme, Norwich Research Park, Norwich, UK.
  • Klunder M; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Joosten R; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands.
  • Demmers JAA; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands.
  • van Gent D; Proteomics Center, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Mouton JW; Department of Molecular Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van der Spek PJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van der Oost J; Clinical Bioinformatics, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van Baarlen P; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands.
  • Louwen R; Host-Microbe Interactomics Group, University of Wageningen, Wageningen, Netherlands.
Sci Adv ; 6(25): eaaz4849, 2020 06.
Article en En | MEDLINE | ID: mdl-32596446
ABSTRACT
CRISPR-Cas9 systems are enriched in human pathogenic bacteria and have been linked to cytotoxicity by an unknown mechanism. Here, we show that upon infection of human cells, Campylobacter jejuni secretes its Cas9 (CjeCas9) nuclease into their cytoplasm. Next, a native nuclear localization signal enables CjeCas9 nuclear entry, where it catalyzes metal-dependent nonspecific DNA cleavage leading to cell death. Compared to CjeCas9, native Cas9 of Streptococcus pyogenes (SpyCas9) is more suitable for guide-dependent editing. However, in human cells, native SpyCas9 may still cause some DNA damage, most likely because of its ssDNA cleavage activity. This side effect can be completely prevented by saturation of SpyCas9 with an appropriate guide RNA, which is only partially effective for CjeCas9. We conclude that CjeCas9 plays an active role in attacking human cells rather than in viral defense. Moreover, these unique catalytic features may therefore make CjeCas9 less suitable for genome editing applications.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Campylobacter jejuni / Proteína 9 Asociada a CRISPR Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Campylobacter jejuni / Proteína 9 Asociada a CRISPR Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article